In diabetes war, Novo Nordisk aims to break mold with new pill

LONDON (Reuters) – After nearly a century building a company worth $125 billion based on injectable drugs, Denmark’s Novo Nordisk – the world’s biggest insulin maker – wants to prove this year it can transform the diabetes market with a pill.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *